COLL

Collegium Pharmaceutical, Inc. Common Stock

22.45

USD

-0.33

-1.45%

Sep 23, 16:00 UTC -4

Closed

After-Market

22.48

+0.03

+0.13%

COLL Earnings Reports

Positive Surprise Ratio

COLL beat 21 of 43 last estimates.

49%

Next Report

Date of Next Report

Nov 04, 2026

Estimate for Q3 26 (Revenue/ EPS)

$222.33M

$1.85

Implied change from Q2 26 (Revenue/ EPS)

+11.23%

-3.65%

Implied change from Q3 25 (Revenue/ EPS)

+6.19%

-17.78%

Collegium Pharmaceutical, Inc. Common Stock earnings per share and revenue

On Aug 06, 2026, COLL reported earnings of 1.92 USD per share (EPS) for Q2 26, beating the estimate of 1.74 USD, resulting in a 9.75% surprise. Revenue reached 199.88 million, compared to an expected 205.23 million, with a -2.61% difference. The market reacted with a -18.55% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 5 analysts forecast an EPS of 1.85 USD, with revenue projected to reach 222.33 million USD, implying an decrease of -3.65% EPS, and increase of 11.23% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Champions Oncology, Inc.

Report Date

Sep 10, 2026 For Q1 27

Estimate

-$0.01

Actual

-$0.03

Surprise

-194.12%

PharmaCyte Biotech, Inc. Common Stock

Report Date

Sep 14, 2026 For Q1 27

Estimate

Actual

-$0.54

Surprise

FAQ

What were Collegium Pharmaceutical, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Collegium Pharmaceutical, Inc. Common Stock reported EPS of $1.92, beating estimates by 9.75%, and revenue of $199.88M, -2.61% below expectations.

How did the market react to Collegium Pharmaceutical, Inc. Common Stock's Q2 2026 earnings?

The stock price moved down -18.55%, changed from $35.74 before the earnings release to $29.11 the day after.

When is Collegium Pharmaceutical, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 04, 2026.

What are the forecasts for Collegium Pharmaceutical, Inc. Common Stock's next earnings report?

Based on 5 analysts, Collegium Pharmaceutical, Inc. Common Stock is expected to report EPS of $1.85 and revenue of $222.33M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.